Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.

Righetti M, Ferrario GM, Milani S, Serbelloni P, La Rosa L, Uccellini M, Sessa A.

Med Sci Monit. 2003 Apr;9(4):PI19-24.

PMID:
12709680
2.

Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.

J Nephrol. 2003 Jul-Aug;16(4):522-34.

PMID:
14696754
3.

Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.

Righetti M, Serbelloni P, Milani S, Ferrario G.

Blood Purif. 2006;24(4):379-86. Epub 2006 Jun 1.

PMID:
16755160
4.

Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.

Sunder-Plassmann G, Födinger M, Buchmayer H, Papagiannopoulos M, Wojcik J, Kletzmayr J, Enzenberger B, Janata O, Winkelmayer WC, Paul G, Auinger M, Barnas U, Hörl WH.

J Am Soc Nephrol. 2000 Jun;11(6):1106-16.

5.

Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.

Tungkasereerak P, Ong-ajyooth L, Chaiyasoot W, Ong-ajyooth S, Leowattana W, Vasuvattakul S, Vareesangthip K, Shayakul C, Chanchairujira T, Sritippayawan S.

J Med Assoc Thai. 2006 Aug;89(8):1187-93.

PMID:
17048428
6.

Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.

Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM.

Hemodial Int. 2007 Apr;11(2):210-6.

PMID:
17403173
7.

[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].

Lovcić V, Kes P, Zeljko R, Kusec V.

Acta Med Croatica. 2006 Jun;60(3):201-8. Croatian.

PMID:
16933832
8.

Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.

Ossareh S, Shayan-Moghaddam H, Salimi A, Asgari M, Farrokhi F.

Iran J Kidney Dis. 2009 Oct;3(4):227-33. Erratum in: Iran J Kidney Dis. 2010 Jan;4(1):88. Salimi, Ashraf [added]; Asgari, Mojgan [added].

9.

Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.

Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J.

Isr Med Assoc J. 2004 Apr;6(4):213-7.

10.

Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.

Elian KM, Hoffer LJ.

Metabolism. 2002 Jul;51(7):881-6.

PMID:
12077735
11.

Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.

Polkinghorne KR, Zoungas S, Branley P, Villanueva E, McNeil JJ, Atkins RC, McGrath BP, Kerr PG.

Intern Med J. 2003 Nov;33(11):489-94.

PMID:
14656250
12.

Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.

Dierkes J, Domröse U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C.

Clin Nephrol. 1999 Feb;51(2):108-15.

PMID:
10069646
13.

Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.

Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.

Saudi J Kidney Dis Transpl. 2009 Sep;20(5):779-88.

14.

Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

Bostom AG, Shemin D, Bagley P, Massy ZA, Zanabli A, Christopher K, Spiegel P, Jacques PF, Dworkin L, Selhub J.

Circulation. 2000 Jun 20;101(24):2829-32. Erratum in: Circulation 2000 Aug 1;102(5):598.

15.

Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.

Dierkes J, Domröse U, Bosselmann KP, Neumann KH, Luley C.

J Ren Nutr. 2001 Apr;11(2):67-72.

PMID:
11295026
16.

Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients.

Righetti M, Tommasi A, Lagona C, La Rosa L, Uccellini M, Sessa A.

Perit Dial Int. 2004 Jul-Aug;24(4):373-7.

17.

[Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].

Kárpáti I, Balla J, Szóke G, Bereczky Z, Páll D, Ben T, Toma K, Katona E, Mohácsi A, Paragh G, Varga Z, Kakuk G, Muszbek L.

Orv Hetil. 2002 Jul 7;143(27):1635-40. Hungarian.

PMID:
12180000
18.

Elevated homocysteine levels in patients with end-stage renal disease.

Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ.

Mt Sinai J Med. 2005 Nov;72(6):365-73.

PMID:
16358160
19.

Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.

Bernasconi AR, Liste A, Del Pino N, Rosa Diez GJ, Heguilén RM.

Nephrology (Carlton). 2006 Apr;11(2):137-41.

PMID:
16669976
20.

[Homocysteine and its metabolites in chronic renal insufficiency and the effect of a vitamin replacement].

Henning BF, Tepel M, Graefe U, Zidek W.

Med Klin (Munich). 2000 Sep 15;95(9):477-81. German.

PMID:
11028163
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk